Clinical Trial

Evaluation of an Intensified Systematic Screening for Congenital Hypothyroidism in Premature Newborns

Study acronym: PREMATHYRO
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Currently in France, screening for congenital hypothyroidism (CH) in premature infants is done by a single TSH assay on filter paper. However, European recommendations advise repeating the assay within the first month of life. Our primary objective is to estimate the incidence of CH in preterm infants under 32 weeks of gestational age by applying the European recommendations.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-13.
Trial Details
NCT Number NCT07425028
Lead Sponsor University Hospital, Lille
Conditions Congenital Hypothyroidism
Enrollment 1,600 participants
Start Date 2027-03
Primary Completion 2028-03 (estimated)
Study Completion 2028-03 (estimated)
Updated on ClinicalTrials.gov 2026-05-22